USC Biomedical Engineering Institute Seeks Investment Director

The Alfred E. Mann Institute at the University of Southern California aims to invest in biotech startups.



The University of Southern California’s Alfred E. Mann Institute for Biomedical Engineering is looking for the institution’s managing director of research investments,
a job posting for the position states. The managing director will act as a general partner for the institution’s venture investing arm.

The institute, managed by USC’s Office of Research and Innovation, provides seed funding to biomedicine research and startups working on commercial biomedical innovations.

The new managing director will work closely with Mann’s advisory committee “to oversee operations and strategic funding priorities of the institute, establish the institute’s strategic agenda, and coordinate other matters related to the institute’s operations and funding priorities,” according to the job posting.

Requirements for the position include at least seven years of experience in investing, preferably at other institutional investors such as endowments, foundations, pension funds, consultants or a fund of funds. There is a preference for candidates with an MBA and at least 10 years of experience.

For more stories like this, sign up for the CIO Alert daily newsletter.

According to the job description, the institute seeks a candidate who has established relationships with venture capital firms, their GPs and limited partners, and institutional investors such as pension funds, family offices and other institutional LPs that make investments in sectors such as health technology. 

The institute works closely with other venture capital and incubator groups within USC, such as the Viterbi Startup Garage, the Marshall/Greif Incubator and the Viterbi Venture Fund. The job posting lists a salary range from $275,767.44 through $310,000. The successful candidate will report to the associate vice president of research strategy and innovation.

Related Stories: 

NYU Appoints Michelle Knudsen as CIO of $5.9B Endowment 

How Endowments Can Evaluate Their Sustainability Levels 

Why Battered Biotech May Be Turning Around 

Tags: , , , ,

«